Please assess the completion status of the following clinical trial:

Trial Title: Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* duration of type 1 diabetes longer than 12months,~* insulin pump therapy longer than 3 months,~* written informed consent to participate in the study signed by parents (and patient older than 16 years).~Exclusion Criteria:~* celiac disease,~* diabetes related complications (e.g. nephropathy),~* BMI at or above the 95th percentile and at or below 3rd percentiles for children and teenagers of the same age and sex,~* withdrawal of consent to participate in the study,~* comorbid conditions and treatment which could significantly affect glycemic values in the researchers' opinion.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Normal Bolus (Type: ACTIVE_COMPARATOR): Pre-breakfast insulin will be given as a Normal Bolus 15 minutes before the high-glycemic index meal (cornflakes and milk). The Normal Bolus will be calculated based on individual insulin-to-carbohydrate ratio (ICR).
- Super Bolus (Type: EXPERIMENTAL): Pre-breakfast insulin will be given as a Super Bolus 15 minutes before the high-glycemic index meal (cornflakes and milk). The Super Bolus will be calculated based on individual ICR increased to 150% and basal insulin will be suspended for 2 hours at the same time.

Based on this trial design, predict the completion outcome and termination type (if applicable).